Investigation of circRNA-miRNA-mRNA network in colorectal cancer using an integrative bioinformatics approach

Sepideh Kadkhoda1,2, Farzaneh Darbeheshti1,3,2, Nima Rezaei4,5,6

  • 1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Insights

This study integrates coding and non-coding RNA data to map colorectal cancer (CRC) molecular interactions. It identifies key circRNAs, miRNAs, and mRNAs, revealing potential diagnostic and therapeutic biomarkers for CRC.

Area of Science:

  • Genomics
  • Bioinformatics
  • Molecular Biology

Background:

  • Competing endogenous RNAs (ceRNAs), particularly circRNAs, are a focus in cancer research.
  • The specific roles and mechanisms of ceRNAs in colorectal cancer (CRC) development are largely unknown.

Purpose of the Study:

  • To integrate coding and non-coding microarray data for colorectal cancer (CRC) using bioinformatics.
  • To create a comprehensive pathobiologic map of molecular interactions and functions in CRC development.

Main Methods:

  • Analysis of Gene Expression Omnibus (GEO) microarray data.
  • Construction of circRNA-miRNA-mRNA, co-expression, and protein-protein interaction (PPI) networks.
  • Principal Component Analysis (PCA) to distinguish tumor and normal tissues based on RNA expression profiles.

Main Results:

  • PCA successfully differentiated colorectal tumors from normal tissues using mRNA, circRNA, and miRNA expression profiles.
  • Identified 36 differentially expressed (DE) circRNAs, 85 DE miRNAs, and 14 DE mRNAs.
  • Constructed a circRNA-miRNA-mRNA network, identifying potential oncogenic (circ_0014879) and tumor-suppressive (circ_0001666, circ_0000977) circRNAs.
  • PPI network highlighted DOCK2 and PTPRC dysregulation in CRC progression, potentially aiding immune evasion.

Conclusions:

  • A novel regulatory network involving DE circRNAs, miRNAs, and mRNAs in CRC development was proposed.
  • DE circRNAs play upstream roles in the oncotranscriptomic cascade of CRC.
  • Identified circRNAs show potential as prognostic and therapeutic biomarkers for CRC.